1-3 of 3
Anita I. Kapanen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels

Catherine A. Tucker, Anita I. Kapanen, Ghania Chikh, Brad G. Hoffman, Alastair H. Kyle, Ian M. Wilson, Dana Masin, Randy D. Gascoyne, Marcel Bally, Richard J. Klasa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 749–758.
https://doi.org/10.1158/1535-7163.MCT-07-0302
Published: 15 April 2008
View article titled, Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels
Open the PDF for Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels in another window
Journal Articles

Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs

Gigi N.C. Chiu, Lincoln A. Edwards, Anita I. Kapanen, Melina M. Malinen, Wieslawa H. Dragowska, Corinna Warburton, Ghania G. Chikh, Karen Y.Y. Fang, Sophia Tan, Jonathan Sy, Catherine Tucker, Dawn N. Waterhouse, Richard Klasa, Marcel B. Bally
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (3): 844–855.
https://doi.org/10.1158/1535-7163.MCT-06-0159
Published: 15 March 2007
View article titled, Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs
Open the PDF for Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs in another window
Journal Articles

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

Minna Tanner, Anita I. Kapanen, Teemu Junttila, Olayinka Raheem, Seija Grenman, Jussi Elo, Klaus Elenius, Jorma Isola
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (12): 1585–1592.
https://doi.org/10.1158/1535-7163.1585.3.12
Published: 04 January 2005
View article titled, Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
Open the PDF for Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer in another window